Phase I/II and pharmacokinetic study of combination chemotherapy with S-1 and oxaliplatin in patients with previously untreated metastatic or recurrent gastric cancer

被引:0
|
作者
Park, I. [1 ]
Lee, J. [1 ]
Ryu, M. [1 ]
Chang, H. [1 ]
Kim, T. [1 ]
Sym, S. [1 ]
Lee, S. [1 ]
Jang, G. [1 ]
Bae, K. [1 ]
Kang, Y. [1 ]
机构
[1] Asan Med Ctr, Seoul, South Korea
关键词
D O I
10.1200/jco.2008.26.15_suppl.4557
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4557
引用
收藏
页数:1
相关论文
共 50 条
  • [21] PHASE II STUDY OF S-1 COMBINED WITH IRINOTECAN AND OXALIPLATIN (TIROX) IN PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL CANCER (MCRC)
    Hong, Y. S.
    Kim, S. Y.
    Park, J. W.
    Lim, S.
    Choi, H. S.
    Jeong, S. Y.
    Kim, D. Y.
    Hong, C. W.
    Sohn, D. K.
    Jung, K. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 136 - 136
  • [22] A PHASE II STUDY OF S-1 AND OXALIPLATIN AS FIRST-LINE THERAPY FOR PATIENTS WITH RECURRENT OR METASTATIC GASTRIC CANCER
    Kim, H. G.
    Kang, M.
    Kim, S.
    Lee, S. I.
    Lee, G.
    Kang, J. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 182 - 182
  • [23] A phase II study of S-1 and oxaliplatin as first-line therapy for patients with recurrent or metastatic gastric cancer
    Kim, H.
    Lee, G.
    Kim, H.
    Lee, O.
    Hwang, I.
    Kang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer
    Hyeong Su Kim
    Min-Hee Ryu
    Dae Young Zang
    Baek-Yeol Ryoo
    Dae Hyun Yang
    Ji Woong Cho
    Man Sup Lim
    Min-Jeong Kim
    Boram Han
    Dae Ro Choi
    Jung Han Kim
    Joo Young Jung
    Hunho Song
    Choong Kee Park
    Yoon-Koo Kang
    Gastric Cancer, 2016, 19 : 579 - 585
  • [25] Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer
    Kim, Hyeong Su
    Ryu, Min-Hee
    Zang, Dae Young
    Ryoo, Baek-Yeol
    Yang, Dae Hyun
    Cho, Ji Woong
    Lim, Man Sup
    Kim, Min-Jeong
    Han, Boram
    Choi, Dae Ro
    Kim, Jung Han
    Jung, Joo Young
    Song, Hunho
    Park, Choong Kee
    Kang, Yoon-Koo
    GASTRIC CANCER, 2016, 19 (02) : 579 - 585
  • [26] Phase II study of CDOP + S-1 combination chemotherapy for advanced and recurrent gastric cancer
    Tsuji, A
    Morita, S
    Shima, Y
    Nishioka, Y
    Horimi, T
    Shirasaka, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 350S - 350S
  • [27] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Sato, Yasushi
    Takayama, Tetsuji
    Sagawa, Tamotsu
    Takahashi, Yasuo
    Ohnuma, Hiroyuki
    Okubo, Syunichi
    Shintani, Naoaki
    Tanaka, Shingo
    Kida, Masaya
    Sato, Yasuhiro
    Ohta, Hidetoshi
    Miyanishi, Koji
    Sato, Tsutomu
    Takimoto, Rishu
    Kobune, Masayoshi
    Yamaguchi, Koji
    Hirata, Koichi
    Niitsu, Yoshiro
    Kato, Junji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 721 - 728
  • [28] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Yasushi Sato
    Tetsuji Takayama
    Tamotsu Sagawa
    Yasuo Takahashi
    Hiroyuki Ohnuma
    Syunichi Okubo
    Naoaki Shintani
    Shingo Tanaka
    Masaya Kida
    Yasuhiro Sato
    Hidetoshi Ohta
    Koji Miyanishi
    Tsutomu Sato
    Rishu Takimoto
    Masayoshi Kobune
    Koji Yamaguchi
    Koichi Hirata
    Yoshiro Niitsu
    Junji Kato
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 721 - 728
  • [29] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Sato, Y.
    Takayama, T.
    Sagawa, T.
    Tanaka, S.
    Takahashi, S.
    Takimoto, R.
    Kato, J.
    Ohnuma, H.
    Takahashi, Y.
    Niitsu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    T Takayama
    Y Sato
    T Sagawa
    T Okamoto
    H Nagashima
    Y Takahashi
    H Ohnuma
    G Kuroiwa
    K Miyanishi
    R Takimoto
    T Matsunaga
    J Kato
    K Yamaguchi
    K Hirata
    Y Niitsu
    British Journal of Cancer, 2007, 97 : 851 - 856